INTERNATIONAL PATENT: BIOLEXIS THERAPEUTICS, INC. FILES APPLICATION FOR "GLP-1 AGONISTS AND METHODS OF USE"

GENEVA, Dec. 31 -- BIOLEXIS THERAPEUTICS, INC. (3900 N Traverse Mountain Blvd., Suite # 200Lehi, Utah 84043) filed a patent application (PCT/US2025/034243) for "GLP-1 AGONISTS AND METHODS OF USE" on Jun 18, 2025. With publication no. WO/2025/264849, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VANKAYALAPATI, Hariprasad (c/o Biolexis Therapeutics, Inc.3900 N Traverse Mountain Blvd., Suite # 200Lehi, Utah 84043), LI, Zhaoliang (c/o Biolexis Therapeutics, Inc.3900 N Traverse Mountain Blvd., Suite # 200Lehi, Utah 84043), L...